Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
66,399,673
-
Total 13F shares
-
39,249,591
-
Share change
-
-2,011,244
-
Total reported value
-
$850,611,960
-
Put/Call ratio
-
284%
-
Price per share
-
$21.67
-
Number of holders
-
114
-
Value change
-
-$43,715,003
-
Number of buys
-
53
-
Number of sells
-
47
Institutional Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q3 2020
As of 30 Sep 2020 RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) had 114 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 39,249,591 shares of stock of the company.
Largest 10 holders included RA CAPITAL MANAGEMENT, L.P., NEA Management Company, LLC, JANUS HENDERSON GROUP PLC, PRIMECAP MANAGEMENT CO/CA/, BlackRock Inc., BAKER BROS. ADVISORS LP, WELLINGTON MANAGEMENT GROUP LLP, FEDERATED HERMES, INC., MPM ASSET MANAGEMENT LLC, and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C).
This table shows 114 institutional shareholders of the security as of 30 Sep 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.